Arcturus Therapeutics Holdings, Inc. (ARCT)
7.57
+0.55
(+7.83%)
USD |
NASDAQ |
Feb 06, 16:00
7.56
-0.01
(-0.13%)
After-Hours: 20:00
Arcturus Therapeutics Holdings SG&A Expense (TTM) : 44.43M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Inovio Pharmaceuticals, Inc. | 33.07M |
| Perspective Therapeutics, Inc. | 31.53M |
| Capricor Therapeutics, Inc. | 21.94M |
| Myomo, Inc. | 32.71M |
| Quanterix Corp. | 132.61M |